Literature DB >> 16891190

Effects of storage time and exogenous protease inhibitors on plasma protein levels.

Saleh Ayache1, Monica Panelli, Francesco M Marincola, David F Stroncek.   

Abstract

Plasma biomarker analysis requires intact unbiased starting material. We analyzed the effects on plasma protein profiles of protease inhibitor cocktails and preprocessing storage. Plasma from 12 healthy subjects collected with and without protease inhibitors was prepared immediately and after 2 hours of room temperature storage. The samples were analyzed by a multiplexed enzyme-linked immunosorbent assay that captured 99 chemokines and cytokines. Unsupervised hierarchical analysis clustered the samples into 4 groups; one composed predominantly of samples processed immediately, another of samples processed after 2 hours, and the remaining two were a mix of immediate and 2-hour samples. The mixed and immediate group protein profiles were similar. However, among the immediate and 2-hour samples, the levels of 37 factors differed significantly: all were greater after 2 hours. The dramatic changes in protein levels during storage were independent of protease inhibitors and are likely due to cytokine production and/or release by leukocytes and platelets.

Mesh:

Substances:

Year:  2006        PMID: 16891190     DOI: 10.1309/3WM7-XJ7R-D8BC-LNKX

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  23 in total

1.  A tumor vessel-targeting fusion protein elicits a chemotherapeutic bystander effect in pancreatic ductal adenocarcinoma.

Authors:  Chun-Te Chen; Yi-Chun Chen; Yi Du; Zhenbo Han; Haoqiang Ying; Richard R Bouchard; Jennifer L Hsu; Jung-Mao Hsu; Trevor M Mitcham; Mei-Kuang Chen; Hui-Lung Sun; Shih-Shin Chang; Donghui Li; Ping Chang; Ronald A DePinho; Mien-Chie Hung
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

2.  Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation.

Authors:  Alessandra Luchini; David H Geho; Barney Bishop; Duy Tran; Cassandra Xia; Robert L Dufour; Clinton D Jones; Virginia Espina; Alexis Patanarut; Weidong Zhou; Mark M Ross; Alessandra Tessitore; Emanuel F Petricoin; Lance A Liotta
Journal:  Nano Lett       Date:  2007-12-13       Impact factor: 11.189

Review 3.  Identification of evidence-based biospecimen quality-control tools: a report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group.

Authors:  Fotini Betsou; Elaine Gunter; Judith Clements; Yvonne DeSouza; Katrina A B Goddard; Fiorella Guadagni; Wusheng Yan; Amy Skubitz; Stella Somiari; Trina Yeadon; Rodrigo Chuaqui
Journal:  J Mol Diagn       Date:  2012-11-27       Impact factor: 5.568

4.  Silk-based blood stabilization for diagnostics.

Authors:  Jonathan A Kluge; Adrian B Li; Brooke T Kahn; Dominique S Michaud; Fiorenzo G Omenetto; David L Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

5.  Nanoparticle technology: Addressing the fundamental roadblocks to protein biomarker discovery.

Authors:  Alessandra Luchini; Caterina Longo; Virginia Espina; Emanuel F Petricoin; Lance A Liotta
Journal:  J Mater Chem       Date:  2009-08-07

Review 6.  Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers.

Authors:  Lisa H Butterfield; A Karolina Palucka; Cedrik M Britten; Madhav V Dhodapkar; Leif Håkansson; Sylvia Janetzki; Yutaka Kawakami; Thomas-Oliver Kleen; Peter P Lee; Cristina Maccalli; Holden T Maecker; Vernon C Maino; Michele Maio; Anatoli Malyguine; Giuseppe Masucci; Graham Pawelec; Douglas M Potter; Licia Rivoltini; Lupe G Salazar; Dolores J Schendel; Craig L Slingluff; Wenru Song; David F Stroncek; Hideaki Tahara; Magdalena Thurin; Giorgio Trinchieri; Sjoerd H van Der Burg; Theresa L Whiteside; Jon M Wigginton; Francesco Marincola; Samir Khleif; Bernard A Fox; Mary L Disis
Journal:  Clin Cancer Res       Date:  2011-05-10       Impact factor: 12.531

Review 7.  Nanoparticle technology: addressing the fundamental roadblocks to protein biomarker discovery.

Authors:  A Luchini; C Fredolini; B H Espina; F Meani; A Reeder; S Rucker; E F Petricoin; L A Liotta
Journal:  Curr Mol Med       Date:  2010-03       Impact factor: 2.222

8.  Effects of anticoagulants on human plasma soluble corin levels measured by ELISA.

Authors:  Ningzheng Dong; Jing Dong; Peng Liu; Luyao Xu; Sengseng Shi; Qingyu Wu
Journal:  Clin Chim Acta       Date:  2010-08-26       Impact factor: 3.786

9.  On Comprehensive Mass Spectrometry Data Analysis for Proteome Profiling of Human Blood Samples.

Authors:  Sameer Manchanda; Mikaela Meyer; Qianqian Li; Kai Liang; Yan Li; Nan Kong
Journal:  J Healthc Inform Res       Date:  2018-05-22

10.  A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers".

Authors:  Lisa H Butterfield; Mary L Disis; Bernard A Fox; Peter P Lee; Samir N Khleif; Magdalena Thurin; Giorgio Trinchieri; Ena Wang; Jon Wigginton; Damien Chaussabel; George Coukos; Madhav Dhodapkar; Leif Håkansson; Sylvia Janetzki; Thomas O Kleen; John M Kirkwood; Cristina Maccalli; Holden Maecker; Michele Maio; Anatoli Malyguine; Giuseppe Masucci; A Karolina Palucka; Douglas M Potter; Antoni Ribas; Licia Rivoltini; Dolores Schendel; Barbara Seliger; Senthamil Selvan; Craig L Slingluff; David F Stroncek; Howard Streicher; Xifeng Wu; Benjamin Zeskind; Yingdong Zhao; Mai-Britt Zocca; Heinz Zwierzina; Francesco M Marincola
Journal:  J Transl Med       Date:  2008-12-23       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.